MLM Stock Analysis: Martin Marietta Materials | NYSE
Building Materials | NYSE, USA | Market Cap: 34.226m USD | 12M Return: 1.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 372M
EPS Trend: 51.1%
Qual. Beats: 0
Rev. Trend: -10.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Martin Marietta Materials, Inc. is a natural resource-based building materials company that supplies aggregates (crushed stone, sand, and gravel) and heavy-side building materials, including ready mixed concrete, asphalt, and paving products and services, to construction markets across the United States and internationally. The company reports through two geographic segments, East Group and West Group, and serves infrastructure, nonresidential, and residential construction end-markets, as well as the railroad, agricultural, utility, and environmental industries. Beyond aggregates, it produces magnesia-based chemicals and dolomitic lime used in steel production, soil stabilization, flame retardants, wastewater treatment, and pulp and paper applications. The company was founded in 1939 and is headquartered in Raleigh, North Carolina.
Operating within the GICS Construction Materials sub-industry, Martin Marietta benefits from a vertically integrated quarry-to-product model in which aggregate reserves are the primary economic moat, as nearby permitted sources are difficult to replicate. Demand for its products is closely tied to public infrastructure spending, private nonresidential construction cycles, and residential housing activity, making the business sensitive to interest rates, government funding programs (such as federal highway allocations), and regional construction trends.
- Infrastructure bill spending drives aggregates demand and pricing power
- Magnesia chemicals margins track steel production and industrial demand
- Acquisition strategy expands aggregates reserves in Sun Belt markets
| Net Income: 2.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.56 > 1.0 |
| NWC/Revenue: 18.80% < 20% (prev 17.60%; Δ 1.20% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.79b > Net Income 2.53b |
| Net Debt (5.81b) to EBITDA (2.14b): 2.72 < 3 |
| Current Ratio: 2.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.4m) vs 12m ago -0.98% < -2% |
| Gross Margin: 29.50% > 18% (prev 29.25%; Δ 0.25% > 0.5%) |
| Asset Turnover: 34.29% > 50% (prev 37.45%; Δ -3.16% > 0%) |
| Interest Coverage Ratio: 6.49 > 6 (EBIT TTM 1.49b / Interest Expense TTM 229.0m) |
| A: 0.06 (Total Current Assets 2.27b - Total Current Liabilities 1.03b) / Total Assets 20.5b |
| B: 0.37 (Retained Earnings 7.66b / Total Assets 20.5b) |
| C: 0.08 (EBIT TTM 1.49b / Avg Total Assets 19.1b) |
| D: 1.23 (Book Value of Equity 11.3b / Total Liabilities 9.20b) |
| Altman-Z'' = 3.42 = A |
| DSRI: 1.08 (Receivables 780.0m/733.0m, Revenue 6.55b/6.64b) |
| GMI: 0.99 (GM 29.25% / 29.50%) |
| AQI: 0.87 (AQ_t 0.25 / AQ_t-1 0.29) |
| SGI: 0.99 (Revenue 6.55b / 6.64b) |
| TATA: 0.04 (NI 2.53b - CFO 1.79b) / TA 20.5b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 571.90 with a total of 393,821 shares traded. Over the past week, the price has changed by -1.27%, over one month by -0.06%, over three months by -8.44% and over the past year by +1.40%.
Current recommended Stop Loss: 542.80 (which is 5.1% or 1.4 ATR below the current price).
Martin Marietta Materials has received a consensus analysts rating of 4.04. Therefore, it is recommended to buy MLM.
- StrongBuy: 11
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 682 | 19.3% |
P/E Trailing = 35.804
P/E Forward = 30.7692
P/S = 5.3899
P/B = 3.2179
P/EG = 2.9485
Revenue TTM = 6.55b USD
EBIT TTM = 1.49b USD
EBITDA TTM = 2.14b USD
Long Term Debt = 5.29b USD (from longTermDebt, last quarter)
Short Term Debt = 65.0m USD (from shortTermDebt, last quarter)
Debt = 6.08b USD (from shortLongTermDebtTotal, last quarter) + Leases 394.0m
Net Debt = 5.81b USD (calculated: Debt 6.08b - CCE 273.0m)
Enterprise Value = 40.0b USD (34.2b + Debt 6.08b - CCE 273.0m)
Interest Coverage Ratio = 6.49 (Ebit TTM 1.49b / Interest Expense TTM 229.0m)
EV/FCF = 38.72x (Enterprise Value 40.0b / FCF TTM 1.03b)
FCF Yield = 2.58% (FCF TTM 1.03b / Enterprise Value 40.0b)
FCF Margin = 15.78% (FCF TTM 1.03b / Revenue TTM 6.55b)
Net Margin = 38.67% (Net Income TTM 2.53b / Revenue TTM 6.55b)
Gross Margin = 29.50% ((Revenue TTM 6.55b - Cost of Revenue TTM 4.62b) / Revenue TTM)
Gross Margin QoQ = 22.76% (prev 30.51%)
Tobins Q-Ratio = 1.95 (Enterprise Value 40.0b / Total Assets 20.5b)
Interest Expense / Debt = 3.77% (Interest Expense 229.0m / Debt 6.08b)
Taxrate = 20.37% (256.0m / 1.26b)
NOPAT = 1.18b (EBIT 1.49b * (1 - 20.37%))
Current Ratio = 2.19 (Total Current Assets 2.27b / Total Current Liabilities 1.03b)
Debt / Equity = 0.54 (Debt 6.08b / totalStockholderEquity, last quarter 11.3b)
Debt / EBITDA = 2.72 (Net Debt 5.81b / EBITDA 2.14b)
Debt / FCF = 5.62 (Net Debt 5.81b / FCF TTM 1.03b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.26% (Net Income 2.53b / Total Assets 20.5b)
RoE = 25.07% (Net Income TTM 2.53b / Total Stockholder Equity 10.1b)
RoCE = 9.65% (EBIT 1.49b / Capital Employed (Equity 10.1b + L.T.Debt 5.29b))
RoIC = 6.15% (NOPAT 1.18b / Invested Capital 19.3b)
WACC = 8.16% (E(34.2b)/V(40.3b) * Re(9.08%) + D(6.08b)/V(40.3b) * Rd(3.77%) * (1-Tc(0.20)))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.85 | Cagr: -1.16%
[DCF] Terminal Value 77.97% ; FCFF base≈867.2m ; Y1≈994.1m ; Y5≈1.46b
[DCF] Fair Price = 269.9 (EV 22.0b - Net Debt 5.81b = Equity 16.2b / Shares 60.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 51.10 | EPS CAGR: 3.58% | SUE: 0.44 | # QB: 0
Revenue Correlation: -10.36 | Revenue CAGR: -0.15% | SUE: 0.70 | # QB: 0
EPS current Quarter (2026-06-30): EPS=4.89 | Chg30d=-2.16% | Revisions=-80% | Analysts=15
EPS next Quarter (2026-09-30): EPS=7.15 | Chg30d=+0.15% | Revisions=-13% | Analysts=15
EPS current Year (2026-12-31): EPS=19.45 | Chg30d=+0.19% | Revisions=-55% | GrowthEPS=+3.6% | GrowthRev=+15.8%
EPS next Year (2027-12-31): EPS=22.93 | Chg30d=-0.19% | Revisions=-25% | GrowthEPS=+17.9% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: -49% (up=14, down=44)